Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The AI response states that metronidazole vaginal gel is for intravaginal use only and not for ophthalmic, dermal, or oral use, which is directly supported by the provided label excerpts (Section 2 and the explicit labeling statement). No contradictions were identified.
Category Scores
Accurate Statements
“Metronidazole vaginal gel is not for ophthalmic, dermal or oral use.”
Supported by the provided excerpt from Section 2 (DOSAGE AND ADMINISTRATION).
“FOR INTRAVAGINAL USE ONLY” and “NOT FOR OPHTHALMIC, DERMAL, OR ORAL USE.”
Supported by the provided unnumbered labeling/packaging statement excerpt.
The response concludes the claim is supported and not contradicted.
Consistent with the provided label excerpts for intravaginal-only use and exclusion of ophthalmic/dermal/oral use.
Unsupported Statements
Contradictions
Important Omissions
No additional dosing/administration regimen details (e.g., specific dosing schedule) are provided in the AI response; however, this is not required for evaluating the specific route-of-use claim.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The only substantive claim evaluated is route-of-administration restriction, which is explicitly supported by the provided prescribing information excerpts.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Minor citation mapping ambiguity: the response references Section 2 for route restriction (supported by excerpt), and also references a labeling statement outside numbered sections (supported), but does not provide exact numbering/product mapping beyond what was included in the prompt excerpts.
Suggested Improvement
When citing, quote the exact provided label text for each element and clearly indicate whether the citation is from a numbered section (e.g., Section 2) versus an unnumbered principal display/packaging instruction.